Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity

Cancer Research

Volumn 61, Issue 12, 2001, Pages 4723-4730

  Dawson, Marcia I ^a   Hobbs, Peter D ^b   Peterson, Valerie J ^c   Leid, Mark ^c   Lange, Christopher W ^a   Feng, Kai Chia ^a   Chen, Guo Quan ^a   Gu, Jian ^d   Li, Hui ^d   Kolluri, Siva Kumar ^d   Zhang, Xiao Kun ^d   Zhang, Yuxiang ^e   Fontana, Joseph A ^e  

^a Palo Alto Institute of Molecular Medicine   (United States)

^b SRI INTERNATIONAL   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d BURNHAM INSTITUTE   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ANTINEOPLASTIC AGENT; RETINOID; RETINOID X RECEPTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR INTRINSIC ACTIVITY; TRANSCRIPTION INITIATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; DNA-BINDING PROTEINS; GROWTH INHIBITORS; HELA CELLS; HL-60 CELLS; HUMANS; INTRACELLULAR MEMBRANES; JURKAT CELLS; MEMBRANE POTENTIALS; MITOCHONDRIA; MOLECULAR CONFORMATION; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; RECEPTORS, STEROID; RETINOIDS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0035875023     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Recent developments in receptor-selective receptive retinoids
2. The retinoid receptors
3. Retinoic acid receptors and retinoid X receptor-α down-regulate the transforming growth factor-β1 promoter by antagonizing AP-1 activity
4. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
5. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor
6. Retinoic acid nuclear receptor β (RARβ) inhibits breast carcinoma growth and tumorigenicity
7. RARβ mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells
8. Methylation and silencing of the retinoic acid receptor-β2 gene in breast cancer
9. Orphan receptor COUP-TF is required for RARβ induction, growth inhibition, and apoptosis by retinoic acid in cancer cells
10. General and reproductive toxicology of retinoids
11. Synthetic retinoids and their usefulness in biology and medicine
12. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor β
13. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells
14. Effects of receptor class- and subtype-selective retinoids and an apoptosis-inducing retinoid on the adherent growth of the NIH:OVCAR-3 ovarian cancer cell line in culture
15. Posttranscriptional regulation of the DNA damage-inducible gadd45 gene in human breast carcinoma cells exposed to a novel retinoid
16. p53 mutation and mitotic infidelity
17. Activity of retinoic acid receptor-γ selectively binding retinoids alone and in combination with interferon-γ in breast cancer cell lines
18. Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid (CD437)
19. Involvement of cyclin-dependent kinase activities in CD437-induced apoptosis
20. Retinoid-induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway
21. Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines
22. Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and -independent pathways
23. Retinoic acid receptor γ-selective retinoids exert antiproliferative effects on human melanoma cell growth in vitro
24. Antiproliferative activity and apoptosis induced by retinoic acid receptor-γ selectively binding retinoids in neuroblastoma
25. A synthetic retinoid CD437 induces S-phase arrest and apoptosis
26. Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity
27. Cytochrome c release and apoptosis induced by mitochondrial targeting of orphan receptor TR3 (nur77, NGFI-B)
28. Synthesis, structure-affinity relationships and biological activities of ligands binding to retinoic acid receptor subtypes
29. 9-cis-Retinoic acid: Effects on normal and leukemic hematopoiesis in vitro
30. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors
31. Inhibition of trans-RA-resistant human breast cancer cell growth by retinoid X-receptor-selective retinoids
32. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently
33. Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid dependent gene expression
34. Ligand-induced alteration of the protease sensitivity of retinoid X receptor
35. p300 functions as a coactivator for the peroxisome proliferator-activated receptor α
36. Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor α-interacting protein
37. L regulates the membrane potential and volume homeostasis of mitochondria
38. Overexpression of the Bcl-2 protein increases the half-life of p21Bax
39. Correlation of retinoid binding affinity to RARα with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells
40. Structural basis for isotype selectivity of the human retinoic acid receptor
41. Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARγ
42. 6′-Substituted naphthalene-2-carboxylic acid analogs, a new class of retinoic acid receptor subtype-specific ligands
43. WAF-1/CIP-1 expression in human breast carcinoma cells
44. Identification of a unique binding protein for a novel retinoid inducing cellular apoptosis
45. Mitochondria and apoptosis
46. The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus
47. Bcl-2 family proteins
48. A selective retinoid with high activity against an androgen-resistant prostate cancer cell type
49. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo
50. Implications of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cell
51. N-(4-Hydroxyphenyl)-retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid
52. N-(4-Hydroxyphenyl)-retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma
53. Role of retinoic acid receptor γ in the Rhino mouse and rabbit irritation models of retinoidal activity
54. Lack of involvement of retinoic acid receptor α in retinoid-induced skin irritation in hairless mice